*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Design And Development Of Gemcitabine Nanoemulsion For Pulmonary Delivery

Author: MERRYL D’SILVA, AFRASIM MOIN, RACHNA.M .KUMAR, SIDDARAMAIAH, D.V. GOWDA
Abstract: Objective: Gemcitabine a synthetic pyrimidine nucleoside prodrug with antineoplastic activity. In this study Gemcitabine (GM) nanoemulsion (NE) was developed and evaluated for pulmonary delivery. Method : GM loaded NE was prepared with cremophor RH 40 (oil), PEG 400(co-surfactant) and labrafil M2125Cs(surfactant )in a ratio of 2:1:1. The formulations were evaluated for particle size, zeta potential, pH, in-vitro drug release, rheology studies, and conductivity. Result: The particle size of the blank and drug-loaded NE was found to be 22 nm. The pH of the prepared formulations was well within the limit (6.35 ± 0.02 to 7.01 ± 0.002). The optimized formulation was sterilized by aseptic filtration. From the polarized light microscopy study, the isotopic nature of optimized NE formulation was confirmed. The drug entrapment efficiency and the in-vitro drug release was found to be 89% and 93% respectively. The optimized formulation M2 was found to be stable from the stability studies. Conclusion: The optimized formulation M2 was found to be stable and can be potentially used in pulmonary delivery.
Keyword: Gemcitabine, Nano emulsion, Pulmonary drug delivery
DOI: https://doi.org/10.31838/ijpr/2021.13.01.563
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free